AU2001280507A1 - Use of bioactive glass compositions to stimulate osteoblast production - Google Patents

Use of bioactive glass compositions to stimulate osteoblast production

Info

Publication number
AU2001280507A1
AU2001280507A1 AU2001280507A AU8050701A AU2001280507A1 AU 2001280507 A1 AU2001280507 A1 AU 2001280507A1 AU 2001280507 A AU2001280507 A AU 2001280507A AU 8050701 A AU8050701 A AU 8050701A AU 2001280507 A1 AU2001280507 A1 AU 2001280507A1
Authority
AU
Australia
Prior art keywords
glass compositions
bioactive glass
stimulate osteoblast
osteoblast production
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280507A
Inventor
Lee D.K. Buttery
Larry L. Hench
Jason Maroothynaden
Julia M. Polak
Ioannis D. Xynos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Publication of AU2001280507A1 publication Critical patent/AU2001280507A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C12/00—Powdered glass; Bead compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/10—Ceramics or glasses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02—Inorganic materials
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C3/00—Glass compositions
    • C03C3/04—Glass compositions containing silica
    • C03C3/076—Glass compositions containing silica with 40% to 90% silica, by weight
    • C03C3/097—Glass compositions containing silica with 40% to 90% silica, by weight containing phosphorus, niobium or tantalum
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C4/00—Compositions for glass with special properties
    • C03C4/0007—Compositions for glass with special properties for biologically-compatible glass
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C4/00—Compositions for glass with special properties
    • C03C4/0007—Compositions for glass with special properties for biologically-compatible glass
    • C03C4/0014—Biodegradable glass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/10—Mineral substrates
    • C12N2533/12—Glass

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Geochemistry & Mineralogy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Materials Engineering (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Ceramic Engineering (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001280507A 2000-07-11 2001-07-11 Use of bioactive glass compositions to stimulate osteoblast production Abandoned AU2001280507A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21746000P 2000-07-11 2000-07-11
US60217460 2000-07-11
PCT/US2001/021801 WO2002004606A1 (en) 2000-07-11 2001-07-11 Use of bioactive glass compositions to stimulate osteoblast production

Publications (1)

Publication Number Publication Date
AU2001280507A1 true AU2001280507A1 (en) 2002-01-21

Family

ID=22811172

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280507A Abandoned AU2001280507A1 (en) 2000-07-11 2001-07-11 Use of bioactive glass compositions to stimulate osteoblast production

Country Status (4)

Country Link
EP (1) EP1311656A4 (en)
AU (1) AU2001280507A1 (en)
CA (1) CA2414510A1 (en)
WO (1) WO2002004606A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1592462A1 (en) * 2003-02-14 2005-11-09 The North West London Hospitals NHS Trust Bioactive material for use in stimulating vascularization
GB0526321D0 (en) * 2005-12-23 2006-02-01 Advanced Biotechnologies Inc Silicone composition
CA2710081C (en) * 2007-12-21 2015-11-24 Bone Therapeutics S.A. Human bone-forming cells in the treatment of inflammatory rheumatic diseases
FR3006195B1 (en) 2013-06-03 2018-03-02 Centre National De La Recherche Scientifique IMPLANT WITH CONTROLLED POROSITY
FR3026309B1 (en) 2014-09-29 2017-11-24 Univ Blaise Pascal-Clermont-Ferrand Ii IMPLANT WITH VARIABLE POROSITY IN A HYBRID MATERIAL
US10238507B2 (en) 2015-01-12 2019-03-26 Surgentec, Llc Bone graft delivery system and method for using same
US11116647B2 (en) 2018-04-13 2021-09-14 Surgentec, Llc Bone graft delivery system and method for using same
US10687828B2 (en) 2018-04-13 2020-06-23 Surgentec, Llc Bone graft delivery system and method for using same
FR3088550B1 (en) 2018-11-15 2021-02-26 Univ Clermont Auvergne CONTROLLED POROSITY IMPLANT IN A HYBRID MATERIAL DOPED IN OSTEOINDUCTIVE NUTRIENT
US11896612B2 (en) 2019-03-29 2024-02-13 Board Of Trustees Of Michigan State University Resurrection of antibiotics that MRSA resists by silver-doped bioactive glass-ceramic particles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692786B2 (en) * 1993-07-02 1998-06-18 Materials Evolution And Development Usa, Inc. Implantable system for cell growth control
US5538887A (en) * 1994-02-18 1996-07-23 Charlotte-Mecklenburg Hospital Authority Cell culture apparatus having smooth surface for cell growth thereon

Also Published As

Publication number Publication date
CA2414510A1 (en) 2002-01-17
EP1311656A4 (en) 2009-05-06
WO2002004606A1 (en) 2002-01-17
EP1311656A1 (en) 2003-05-21

Similar Documents

Publication Publication Date Title
WO2001044272A3 (en) Daptomycin analogs as antibacterial agents
PL352708A1 (en) Compositions for imparting desired properties to materials
AU2002230471A1 (en) Surface preparation prior to deposition
AU2002366710A1 (en) USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
AU2002237457A1 (en) Phosphodiesterase 4d genes related to human stroke
AU8148101A (en) Novel process to prepare aqueous formulations
AU2001280507A1 (en) Use of bioactive glass compositions to stimulate osteoblast production
IL159632A0 (en) Process and intermediates to prepare latanoprost
PL373759A1 (en) Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
EP1648839B8 (en) Vitreous compositions of the vitroceramic type, transparent to infrared
AU7334401A (en) Compositions for imparting desired properties to materials
AU2002256304A1 (en) Compositions for delivery of compounds to cells and methods of use
AU2003270101A1 (en) Process of making gel detergent compositions
AU2001280436A1 (en) Process to increase protein stability
AU2003260682A1 (en) Improvements in or relating to perfume compositions
EP1414934B8 (en) Improvements relating to colour-safe fabric treatment compositions
HUP0400075A2 (en) Preparation of pharmaceutical compositions to treat ahdh
AU2001253468A1 (en) Methods and compositions for the treatment of fibrotic conditions and impaired lung function and to enhance lymphocyte production
AU2001273348A1 (en) Purification of human troponin i
HUP0400007A2 (en) Use of an alkanoyl-l-carnitine for the preparation of pharmaceutical composition to treat anhedonia
AU2002251213A1 (en) Use of bioactive glass
GB0022777D0 (en) Improvements in or relating to the manufacture of glass
AUPR575001A0 (en) Improvements in or relating to the production of cultured pearls
GB0129049D0 (en) Improvements to self-sterilisation of surfaces
AUPQ818700A0 (en) Improvements in or relating to the production of cultured pearls